NCT06770842
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Department of Medicine, Queen Mary Hospital Hong Kong
Clinical trial condition
Primary Myelofibrosis
Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.
457 public trials
86 recruiting studies
Primary Myelofibrosis trial results
NCT05423691
- Conditions
- Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
- Locations
-
- UC Davis Health Sacramento, California, United States
- Columbia University New York, United States
- Montefiore Einstein Cancer Center The Bronx, New York, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
Recruiting
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
NCT05025488
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +10 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT06896344
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo di Pavia Pavia, Italy
Recruiting
Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
NCT06605586
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- DE-Aachen-UKAACHEN Aachen, Germany
- NL-Amsterdam-AmsterdamUMC Amsterdam, Netherlands
- NL-Groningen-UMCG Groningen, Netherlands
- NL-Nijmegen-RADBOUDUMC Nijmegen, Netherlands
Recruiting
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
NCT06151119
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT05488548
- Conditions
- Bone Marrow Diseases, Castrate Resistant Prostate Cancer, Chronic Disease, +16 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Azienda Ospedaliera Annunziata Cosenza, Calabria, Italy
- Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria, Calabria, Italy
- Università degli Studi di Napoli Federico II U.O.C. di Ematologia e Trapianti di midollo Naples, Campania, Italy
- IRCCS Policlinico Sant'Orsola Bologna, Emilia-Romagna, Italy
NCT06073847
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Bristol-Myers Squibb YH Seoul, South Korea
- Local Institution - 0001 Seoul, South Korea
- Novotech Laboratory Korea Co., Ltd. Seoul, South Korea
NCT02760238
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +34 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada